# F&M Bank Corp: financial statements, quarterly

FMBM · OTC · CIK 740806 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmbm.md) · [Financials](/companies/fmbm/financials.md) · [Filings](/companies/fmbm/filings.md) · [Insiders](/companies/fmbm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmbm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [96.0 d](/filings/0001654954-23-014253.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [6,628](/filings/0001654954-23-014253.md) | [7,036 d](/filings/0001654954-24-003726.md) | [7,448](/filings/0001654954-25-005678.md) | [7,519](/filings/0001654954-25-009632.md) | [7,797](/filings/0001654954-25-012972.md) | [7,785 d](/filings/0001654954-26-002891.md) | [6,820](/filings/0001654954-26-004803.md) | [6,285](/filings/0001654954-26-007556.md) | [6,557](/filings/0001654954-25-012972.md) | [6,560 d](/filings/0001654954-26-002891.md) | [6,064](/filings/0001654954-26-004803.md) | [5,770](/filings/0001654954-26-007556.md) |
| Income tax | $k | [(44.0)](/filings/0001654954-24-014373.md) | [(220) d](/filings/0001654954-25-003506.md) | [(1.0)](/filings/0001654954-25-005678.md) | [471](/filings/0001654954-25-009632.md) | [(110)](/filings/0001654954-25-012972.md) | [278 d](/filings/0001654954-26-002891.md) | [414](/filings/0001654954-26-004803.md) | [455](/filings/0001654954-26-007556.md) | [445](/filings/0001654954-25-012972.md) | [433 d](/filings/0001654954-26-002891.md) | [478](/filings/0001654954-26-004803.md) | [1,102](/filings/0001654954-26-007556.md) |
| Net income | $k | [1,018](/filings/0001654954-24-014373.md) | [457 d](/filings/0001654954-25-003506.md) | [1,217](/filings/0001654954-25-005678.md) | [3,015](/filings/0001654954-25-009632.md) | [792](/filings/0001654954-25-012972.md) | [2,260 d](/filings/0001654954-26-002891.md) | [2,457](/filings/0001654954-26-004803.md) | [2,965](/filings/0001654954-26-007556.md) | [2,924](/filings/0001654954-25-012972.md) | [2,888 d](/filings/0001654954-26-002891.md) | [3,226](/filings/0001654954-26-004803.md) | [5,369](/filings/0001654954-26-007556.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.35](/filings/0001654954-25-005678.md) | [0.86](/filings/0001654954-25-009632.md) | [0.23](/filings/0001654954-25-012972.md) | not reported | [0.70](/filings/0001654954-26-004803.md) | [0.83](/filings/0001654954-26-007556.md) | [0.82](/filings/0001654954-25-012972.md) | not reported | [0.91](/filings/0001654954-26-004803.md) | [1.50](/filings/0001654954-26-007556.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.84](/filings/0001654954-26-007556.md) | not reported | not reported | not reported | [1.52](/filings/0001654954-26-007556.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q1 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [23.7](/filings/0001654954-24-003726.md) | [52.5](/filings/0001654954-24-006311.md) | [50.5](/filings/0001654954-24-010593.md) | [60.3](/filings/0001654954-24-014373.md) | [57.0](/filings/0001654954-26-002891.md) | [89.5](/filings/0001654954-25-005678.md) | [47.3](/filings/0001654954-25-009632.md) | [83.9](/filings/0001654954-25-012972.md) | [68.9](/filings/0001654954-26-007556.md) | [85.9](/filings/0001654954-26-004803.md) | [60.8](/filings/0001654954-26-007556.md) |
| Total assets | $m | [1,282](/filings/0001654954-23-014253.md) | [1,295](/filings/0001654954-25-003506.md) | [1,316](/filings/0001654954-24-006311.md) | [1,310](/filings/0001654954-24-010593.md) | [1,345](/filings/0001654954-24-014373.md) | [1,302](/filings/0001654954-26-002891.md) | [1,312](/filings/0001654954-25-005678.md) | [1,312](/filings/0001654954-25-009632.md) | [1,358](/filings/0001654954-25-012972.md) | [1,373](/filings/0001654954-26-007556.md) | [1,409](/filings/0001654954-26-004803.md) | [1,397](/filings/0001654954-26-007556.md) |
| Total liabilities | $m | [1,215](/filings/0001654954-23-014253.md) | [1,216](/filings/0001654954-25-003506.md) | [1,238](/filings/0001654954-24-006311.md) | [1,228](/filings/0001654954-24-010593.md) | [1,255](/filings/0001654954-24-014373.md) | [1,216](/filings/0001654954-26-002891.md) | [1,221](/filings/0001654954-25-005678.md) | [1,217](/filings/0001654954-25-009632.md) | [1,257](/filings/0001654954-25-012972.md) | [1,269](/filings/0001654954-26-007556.md) | [1,302](/filings/0001654954-26-004803.md) | [1,285](/filings/0001654954-26-007556.md) |
| Long-term debt | $m | not reported | [6.9](/filings/0001654954-25-003506.md) | not reported | not reported | not reported | [7.0](/filings/0001654954-25-003506.md) | [7.0](/filings/0001654954-25-005678.md) | [7.0](/filings/0001654954-25-009632.md) | [7.0](/filings/0001654954-25-012972.md) | [9.9](/filings/0001654954-26-007556.md) | [9.9](/filings/0001654954-26-004803.md) | [9.9](/filings/0001654954-26-007556.md) |
| Current portion of debt | $m | [6.9](/filings/0001654954-23-014253.md) | [6.9](/filings/0001654954-24-014373.md) | [6.9](/filings/0001654954-24-006311.md) | [7.0](/filings/0001654954-24-010593.md) | [7.0](/filings/0001654954-24-014373.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [60.0](/filings/0001654954-23-014253.md) | [60.0](/filings/0001654954-25-003506.md) | [60.0](/filings/0001654954-24-006311.md) | [20.0](/filings/0001654954-24-010593.md) | [15.0](/filings/0001654954-24-014373.md) | [0.0](/filings/0001654954-25-003506.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [67.0](/filings/0001654954-24-014373.md) | [78.3](/filings/0001654954-26-002891.md) | [77.7](/filings/0001654954-25-009632.md) | [81.6](/filings/0001654954-25-012972.md) | [90.0](/filings/0001654954-25-012972.md) | [85.6](/filings/0001654954-26-007556.md) | [90.7](/filings/0001654954-26-007556.md) | [94.0](/filings/0001654954-26-007556.md) | [101](/filings/0001654954-25-012972.md) | [104](/filings/0001654954-26-007556.md) | [106](/filings/0001654954-26-007556.md) | [112](/filings/0001654954-26-007556.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,230 d](/filings/0001654954-24-014373.md) | [2,292 d](/filings/0001654954-25-003506.md) | [2,942](/filings/0001654954-25-005678.md) | [(435) d](/filings/0001654954-25-009632.md) | [1,101 d](/filings/0001654954-25-012972.md) | [3,525 d](/filings/0001654954-26-002891.md) | [5,517](/filings/0001654954-26-004803.md) | [2,029 d](/filings/0001654954-26-007556.md) | [7,035 d](/filings/0001654954-25-012972.md) | [1,922 d](/filings/0001654954-26-002891.md) | [5,700](/filings/0001654954-26-004803.md) | [5,030 d](/filings/0001654954-26-007556.md) |
| Capital expenditure | $k | [108 d](/filings/0001654954-24-014373.md) | [78.0 d](/filings/0001654954-25-003506.md) | [70.0](/filings/0001654954-25-005678.md) | [83.0 d](/filings/0001654954-25-009632.md) | [66.0 d](/filings/0001654954-25-012972.md) | [63.0 d](/filings/0001654954-26-002891.md) | [131](/filings/0001654954-26-004803.md) | [136 d](/filings/0001654954-26-007556.md) | [113 d](/filings/0001654954-25-012972.md) | [344 d](/filings/0001654954-26-002891.md) | [732](/filings/0001654954-26-004803.md) | [73.0 d](/filings/0001654954-26-007556.md) |
| Dividends paid | $k | not reported | not reported | [905](/filings/0001654954-25-005678.md) | [915 d](/filings/0001654954-25-009632.md) | [915 d](/filings/0001654954-25-012972.md) | [915 d](/filings/0001654954-26-002891.md) | [917](/filings/0001654954-26-004803.md) | [927 d](/filings/0001654954-26-007556.md) | [925 d](/filings/0001654954-25-012972.md) | [924 d](/filings/0001654954-26-002891.md) | [925](/filings/0001654954-26-004803.md) | [932 d](/filings/0001654954-26-007556.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001654954-26-002891.md) | not reported | not reported | not reported | [133 d](/filings/0001654954-26-002891.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.4](/filings/0001654954-22-015149.md) | [3.4](/filings/0001654954-22-006711.md) | [3.5](/filings/0001654954-22-011290.md) | [3.5](/filings/0001654954-22-015149.md) | [3,490](/filings/0001654954-25-005678.md) | [3.5](/filings/0001654954-25-009632.md) | [3.5](/filings/0001654954-25-012972.md) | [3,531](/filings/0001654954-26-004803.md) | [3,564](/filings/0001654954-26-007556.md) | [3.6](/filings/0001654954-25-012972.md) | [3,560](/filings/0001654954-26-004803.md) | [3,584](/filings/0001654954-26-007556.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,586,733 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001654954-26-007556.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.